Range Low Price High Price Comment
30 days $10.70 $14.80 Thursday, 28th Mar 2024 KALV stock ended at $11.86. This is 7.14% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 14.06% from a day low at $10.92 to a day high of $12.46.
90 days $10.70 $16.88
52 weeks $7.21 $16.88

Historical KalVista Pharmaceuticals Inc prices

Date Open High Low Close Volume
2024-03-28 $11.08 $12.46 $10.92 $11.86 2 152 834
2024-03-27 $11.20 $11.41 $10.97 $11.07 259 963
2024-03-26 $11.22 $11.38 $10.70 $11.11 516 722
2024-03-25 $11.74 $11.84 $11.04 $11.13 502 806
2024-03-22 $12.17 $12.29 $11.75 $11.85 261 701
2024-03-21 $12.30 $12.70 $12.07 $12.15 269 484
2024-03-20 $12.00 $12.24 $11.75 $12.23 440 609
2024-03-19 $11.87 $12.36 $11.65 $11.84 449 152
2024-03-18 $11.92 $12.35 $11.70 $11.99 535 992
2024-03-15 $12.42 $12.56 $11.87 $11.93 727 031
2024-03-14 $12.42 $12.57 $12.12 $12.43 454 926
2024-03-13 $12.58 $12.78 $12.42 $12.49 402 174
2024-03-12 $12.86 $13.07 $12.31 $12.49 568 633
2024-03-11 $14.04 $14.44 $13.06 $13.10 664 015
2024-03-08 $14.14 $14.52 $13.77 $14.36 1 199 861
2024-03-07 $13.79 $14.45 $12.87 $14.01 1 125 936
2024-03-06 $14.11 $14.62 $14.05 $14.38 559 419
2024-03-05 $13.91 $14.21 $13.86 $13.98 433 544
2024-03-04 $14.27 $14.27 $13.86 $14.03 411 975
2024-03-01 $13.73 $14.25 $13.68 $14.14 495 190
2024-02-29 $13.58 $13.80 $13.43 $13.65 622 495
2024-02-28 $14.60 $14.64 $13.32 $13.39 956 591
2024-02-27 $13.87 $14.80 $13.82 $14.62 1 034 916
2024-02-26 $13.10 $13.76 $12.72 $13.69 958 650
2024-02-23 $12.50 $12.70 $11.95 $12.58 1 202 050
Click to get the best stock tips daily for free!

About KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ... KALV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT